Get started
Author

Patrícia A. Possik

Observed names: P A Possik, P. A. Possik, P. Abrao Possik, Patricia A Possik, Patricia A. Possik, Patricia Abrao Possik, Patricia Abrão Possik, Patricia Possik, Patricia A. Possik, Patrícia Abrão Possik, Patrícia A Possik, Patrícia Abrão Possik, Possik, Patricia
Observed institutions: The Wistar Institute, Universidade Federal de São Carlos, Universidade de São Paulo, Wellcome Sanger Institute, The Netherlands Cancer Institute, AC Camargo Hospital, Instituto Nacional de Câncer - INCA
ORCID: 0000-0003-2899-0969
Observed ORCID: 0000-0003-2899-0969
OpenAlex ID: A5067165337
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma
2014 · Judith Müller, Oscar Krijgsman, et al. · Nature Communications · 635
PDF
Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis
2012 · Liesbeth C.W. Vredeveld, Patricia A. Possik, et al. · Genes & Development · 262
PDF
Acral lentiginous melanoma: Basic facts, biological characteristics and research perspectives of an understudied disease
2020 · Patricia Basurto‐Lozada, Christian Molina‐Aguilar, et al. · Pigment Cell & Melanoma Research · 156
PDF
The Role of BRAF Mutation and p53 Inactivation during Transformation of a Subpopulation of Primary Human Melanocytes
2009 · Hong Yu, Ronan McDaid, et al. · American Journal Of Pathology · 79
PDF
PhosphoPath: Visualization of Phosphosite-centric Dynamics in Temporal Molecular Networks
2015 · Linsey M. Raaijmakers, Piero Giansanti, et al. · Journal of Proteome Research · 60
ROCK1 is a potential combinatorial drug target for BRAF mutant melanoma
2014 · Marjon A Smit, Gianluca Maddalo, et al. · Molecular Systems Biology · 54
PDF
Acral melanoma: new insights into the immune and genomic landscape
2023 · Larissa Anastacio DaCosta Carvalho, Flavia C. Aguiar, et al. · Neoplasia · 49
Evidence of oncogene-induced senescence in thyroid carcinogenesis
2011 · Maria Grazia Vizioli, Patricia A Possik, et al. · Endocrine Related Cancer · 47
PDF
Cooperative induction of apoptosis in NRAS mutant melanoma by inhibition of MEK and ROCK
2015 · Celia J. Vogel, Marjon A. Smit, et al. · Pigment Cell & Melanoma Research · 44
Parallel In Vivo and In Vitro Melanoma RNAi Dropout Screens Reveal Synthetic Lethality between Hypoxia and DNA Damage Response Inhibition
2014 · Patricia A. Possik, Judith Müller, et al. · Cell Reports · 43
PDF
Poor clinical outcome in metastatic melanoma is associated with a microRNA-modulated immunosuppressive tumor microenvironment
2020 · Natasha A. N. Jorge, Jéssica G. V. Cruz, et al. · Journal of Translational Medicine · 38
PDF
More than just acral melanoma: the controversies of defining the disease
2021 · Sara S Bernardes, Ingrid Ferreira, et al. · The Journal of Pathology Clinical Research · 27
Extracellular vesicle-mediated crosstalk between melanoma and the immune system: Impact on tumor progression and therapy response
2020 · Marco Antônio Marques Pretti, Sara Santos Bernardes, et al. · Journal of Leukocyte Biology · 25
Pro-Apoptotic Antitumoral Effect of Novel Acridine-Core Naphthoquinone Compounds against Oral Squamous Cell Carcinoma
2022 · Bruna Costa Zorzanelli, Gabriel Ouverney, et al. · Molecules · 22
PDF
Mutually exclusive genetic interactions and gene essentiality shape the genomic landscape of primary melanoma
2022 · Sofia Birkeälv, Mark Harland, et al. · The Journal of Pathology · 16
PDF
Protease-activated receptor 2 (PAR2) upregulates granulocyte colony stimulating factor (G-CSF) expression in breast cancer cells
2018 · Érika Carvalho, Vitor Hugo de Almeida, et al. · Biochemical and Biophysical Research Communications · 15
Gene expression profile of human Down syndrome leukocytes.
2005 · Wilson Malagó, César A Sommer, et al. · PubMed · 15
Integrated in vivo genetic and pharmacologic screening identifies co-inhibition of EGRF and ROCK as a potential treatment regimen for triple-negative breast cancer
2016 · Sedef Iskit, Cor Lieftink, et al. · Oncotarget · 13
PDF
TOP1 modulation during melanoma progression and in adaptative resistance to BRAF and MEK inhibitors
2021 · Érica Aparecida de Oliveira, Jagat Chauhan, et al. · Pharmacological Research · 10
Impact of clinical and histopathological characteristics on the disease‐free survival of stage I‐II acral melanoma patients
2023 · Raquel Borges de Barros Primo, Aretha Brito Nobre, et al. · International Journal of Dermatology · 8
PDF
Combined programmed cell death protein 1 and cytotoxic T-lymphocyte associated protein 4 blockade in an international cohort of patients with acral lentiginous melanoma
2024 · Erin McGillivray, Karam Ashouri, et al. · British Journal of Dermatology · 7
PDF
Comprehensive Profiling of Acral Lentiginous Melanoma Reveals Downregulated Immune Activation Compared to Cutaneous Melanoma
2025 · Stephanie J. Wang, Joanne Xiu, et al. · Pigment Cell & Melanoma Research · 6
DSCR2, a Down syndrome critical region protein, is localized to the endoplasmic reticulum of mammalian cells.
2005 · P A Possik, C A Sommer, et al. · PubMed · 5
Ancestry and somatic profile indicate acral melanoma origin and prognosis
2026 · Patricia Basurto-Lozada, Martha Estefania Vázquez-Cruz, et al. · Nature · 4
Exploring Latin America one cell at a time
2025 · Patricia A. Possik, David J. Adams, et al. · Cell · 4
PDF
Works count: 58
Citation count: 1,660
H-index: 15
I10-index: 19
Year
Topic
Type